Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood–Brain Barrier
Cells · 2024
DOI: 10.3390/cells13020190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Yunfei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIMHD NIH HHS, NIH HHS.
Abstract (Originalsprache)
The disruption of endothelial heparan sulfate (HS) is an early event in tumor cell metastasis across vascular barriers, and the reinforcement of endothelial HS reduces tumor cell adhesion to endothelium. Our recent study showed that while vascular endothelial growth factor (VEGF) greatly reduces HS at an in vitro blood–brain barrier (BBB) formed by human cerebral microvascular endothelial cells (hCMECs), it significantly enhances HS on a breast cancer cell, MDA-MB-231 (MB231). Here, we tested that this differential effect of VEGF on the HS favors MB231 adhesion and transmigration. We also tested if agents that enhance endothelial HS may affect the HS of MB231 and reduce its adhesion and transmigration. To test these hypotheses, we generated an in vitro BBB by culturing hCMECs on either a glass-bottom dish or a Transwell filter. We first quantified the HS of the BBB and MB231 after treatment with VEGF and endothelial HS-enhancing agents and then quantified the adhesion and transmigration of MB231 across the BBB after pretreatment with these agents. Our results demonstrated that the reduced/enhanced BBB HS and enhanced/reduced MB231 HS increase/decrease MB231 adhesion to and transmigration across the BBB. Our findings suggest a therapeutic intervention by targeting the HS-mediated breast cancer brain metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.
- Department of Natural Sciences, CASL, University of Michigan-Dearborn, Dearborn, MI 48128, USA.
ORCID-Profile: Jie Fan, Bingmei M Fu
Förderung
- NCATS NIH HHS
- NIMHD NIH HHS
- NIH HHS
- NINDS NIH HHS
- NIH
- ARO (Army Research Office)
- the University of Michigan-Dearborn
Zitieren
APA
Li, Y., Shteyman, D. B., Hachem, Z., Ulay, A. A., Fan, J., & Fu, B. M. (2024). Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood–Brain Barrier. Cells. https://doi.org/10.3390/cells13020190
Vancouver
Li Y, Shteyman DB, Hachem Z, Ulay AA, Fan J, Fu BM. Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood–Brain Barrier. Cells. 2024. doi:10.3390/cells13020190
BibTeX
@article{Li2024,
author = {Li, Yunfei and Shteyman, David B and Hachem, Zeina and Ulay, Afaf A and Fan, Jie and Fu, Bingmei M},
title = {Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood–Brain Barrier},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13020190}
}
EUVIMED